Skip to main content
HCPCS J7644 · Level II · Part B drug

HCPCS J7644: Ipratropium bromide, inhalation solution, fda-approved final product,

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J7644

Billing unit
1 MG
Ipratropium bromide non-comp
ASP payment limit
$0.445
October 2026; +0.2% vs July 2026
Practitioner MUE
3
MAI 3
OPPS status
SI M
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J7644 is the Level II code for Ipratropium bromide, inhalation solution, fda-approved final product,, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.445 per billing unit, up 0.2% from July 2026. The practitioner MUE allows up to 3 units per date of service (MAI 3). Under OPPS it carries status indicator M. J7644 is billed in units of 1 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 22 NDCs to it, sold as Ipratropium Bromide by Mylan Pharmaceuticals Inc., Nephron SC, Inc., Sun Pharmaceutical Global FZE.. No current Billing and Coding Article lists J7644, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J7644 at $0.445 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.444 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J7644
QuarterPayment limitPerCoinsurance
October 2026$0.4451 MG20%
July 2026$0.4441 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 22 NDCs from 8 labelers to J7644. Report the NDC in the claim's drug segment and bill the number of J7644 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J7644
NDCDrug nameLabelerPackage sizeBilling units / package
00378-7970-52Ipratropium BromideMylan Pharmaceuticals Inc.2.5 × 2513
00378-7970-55Ipratropium BromideMylan Pharmaceuticals Inc.2.5 × 3015
00378-7970-91Ipratropium BromideMylan Pharmaceuticals Inc.2.5 × 6030
00378-7970-93Ipratropium BromideMylan Pharmaceuticals Inc.2.5 × 3015
00487-9801-01Ipratropium BromideNephron SC, Inc.2.5 × 3015
00487-9801-25Ipratropium BromideNephron SC, Inc.2.5 × 2513
00487-9801-30Ipratropium BromideNephron SC, Inc.2.5 × 3015
00487-9801-60Ipratropium BromideNephron SC, Inc.2.5 × 6030
47335-0706-49Ipratropium BromideSun Pharmaceutical Global FZE.2.5 × 2513
47335-0706-52Ipratropium BromideSun Pharmaceutical Global FZE.2.5 × 3015
47335-0706-54Ipratropium BromideSun Pharmaceutical Global FZE.2.5 × 6030
50090-0668-00Ipratropium BromideA-S Medication Solutions2.5 × 2513
50090-6373-00Ipratropium BromideA-S Medication Solutions2.5 × 2513
60687-0394-83Ipratropium BromideAmerican Health Packaging2.5 × 3015
62135-0830-84Ipratropium BromideChartwell2.5 × 3015
64980-0640-02Ipratropium BromideRising Pharma Holdings, Inc.2.5 × 2513
64980-0640-03Ipratropium BromideRising Pharma Holdings, Inc.2.5 × 3015
64980-0640-06Ipratropium BromideRising Pharma Holdings, Inc.2.5 × 6030
76204-0100-01Ipratropium BromideRitedose Pharmaceuticals, LLC2.5 × 3015
76204-0100-25Ipratropium BromideRitedose Pharmaceuticals, LLC2.5 × 2513
76204-0100-30Ipratropium BromideRitedose Pharmaceuticals, LLC2.5 × 3015
76204-0100-60Ipratropium BromideRitedose Pharmaceuticals, LLC2.5 × 6030

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J7644. For practitioners the limit is 3 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J7644 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services33 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital03 Date of Service Edit: ClinicalCMS Policy
DME supplier2793 Date of Service Edit: ClinicalPublished Contractor Policy

NCCI edits and add-on relationships

No active practitioner PTP pair lists J7644 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

J7644 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J7644 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J7644 carries status indicator M. Consult the OPPS status indicator table for payment treatment.

Common denials for J7644 and how to prevent them

CARC 16 · M119

NDC missing, invalid or not matched to the HCPCS code

CARC 151 · N362

units billed exceed the MUE for the date of service

CARC 50 · N115

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J7644 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Explore QuickCodeExplore QuickRCMBook a demo

Frequently asked questions — HCPCS J7644

What does HCPCS code J7644 describe?

J7644 is defined by CMS as "Ipratropium bromide, inhalation solution, fda-approved final product,". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J7644 in October 2026?

The ASP-based payment limit is $0.445 per 1 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $0.444.

How many units of J7644 can be billed per day?

The practitioner Medically Unlikely Edit is 3 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J7644?

The October 2026 ASP crosswalk lists 22 NDCs from 8 labelers: Ipratropium Bromide (Mylan Pharmaceuticals Inc.); Ipratropium Bromide (Nephron SC, Inc.); Ipratropium Bromide (Sun Pharmaceutical Global FZE.); Ipratropium Bromide (A-S Medication Solutions). For example NDC 00378-7970-52 is a 2.5 package equal to 13 billing units. The crosswalk's billing-units-per-package figure converts each package into J7644 units.

Does J7644 have NCCI bundling edits?

No active practitioner PTP pairs list J7644 as a column-1 or column-2 code in the v323r0 release. Unit limits (MUE) and medical-necessity coverage rules still apply.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.